Compare Stocks › AXP vs WST

American Express Company (AXP) vs West Pharmaceutical Services, Inc. (WST): Which Is the Better Buy in 2026?

As of 2026-11-01, AXP is undervalued at $319, with a DCF intrinsic value of $462 and a margin of safety of 31%. WST is overvalued at $413, with an intrinsic value of $159 and a margin of safety of -160%. Of the two, AXP has the wider margin of safety.

AXP
American Express Company
$319.11
VS
WST
West Pharmaceutical Services, Inc.
$412.62

Rewards

AXP
  • ★Gross margin of 62.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★American Express Company scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
WST
  • ★West Pharmaceutical Services, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Altman Z-Score of 13.89 indicates very low bankruptcy risk — the company is firmly in the safe zone.
  • ★Net debt/EBITDA of -0.2x means the company holds more cash than debt — a net cash position.

Risks

AXP
  • ⚠Altman Z-Score of 0.93 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠Insiders have sold $3.0M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 5.9% CAGR over the past 4 years — a concerning trend.
WST
  • ⚠FCF yield of 1.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠Trailing P/E of 52.8x is 30% above the historical average of 40.7x — the stock trades at a premium to its own history.
  • ⚠PEG ratio of 3.21 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
AXP
WST
Valuation
N/A
Free Cash Flow
$468.90M
N/A
FCF Yield
1.63%
17.98
Trailing P/E
52.83
15.80
Forward P/E
40.19
Quality & Moat
11.07%
ROIC
20.74%
35.93%
ROE
21.23%
61.95%
Gross Margin
37.59%
1.32
PEG Ratio
3.21
Balance Sheet Safety
0.46
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
N/A
Net Debt / EBITDA
-0.16
1.19%
Dividend Yield
0.25%
AXP: 6Ties: 1WST: 2
AXPWST

Historical Fundamentals

Learn more →
AXP

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

WST

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
AXP
$6.18
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$23.29B
Δ Market Cap
+$144.01B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
WST
$1.70
created per $1 retained over 3 years
Value Creator
Σ Retained
$1.40B
Δ Market Cap
+$2.38B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
AXP
31.0% Margin of Safety
Price is 31.0% below estimated fair value
Current Price: $319.11
Fair Value: $462.42
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
WST
160.3% Overvalued
Price is 160.3% above estimated fair value
Current Price: $412.62
Fair Value: $158.54
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
AXP

Requires positive FCF to compute implied growth rate.

WST

What growth rate is the market pricing in at $413?

+22.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +22.9%

The market implies +22.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +22.9%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
AXP
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
WST
68/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
AXP
-2.51
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
WST
-2.77
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
AXP
Insiders 22.7%Institutions 65.0%Retail & Other 12.2%
No. of Institutional Holders3,716
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
WST
Insiders 0.7%Institutions 103.7%
No. of Institutional Holders1,235
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
AXP
0
Buys (3M)
0
Buys (12M)
JOABAR RAYMOND D
Officer
$4,054
@ $176.26 · 2025-04-09
ANGELAKIS MICHAEL J
Director
$998,593
@ $269.89 · 2025-03-07
Open market purchases · includes direct & indirect ownership · excludes option exercises
WST
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
AXP
1
Sells (3M)
10
Sells (12M)
Total value (12M): $42.29M
HERENA MONIQUE
Officer
$2.97M
@ $337.41 · 2026-08-18
MCNEAL GLENDA G
Officer
$2.39M
@ $339.36 · 2026-06-15
LIEBERMAN QUINN JESSICA
Officer
$909,661
@ $300.02 · 2026-03-06
JOABAR RAYMOND D
Officer
$4.77M
@ $340.67 · 2026-02-19
GROSFIELD HOWARD M
Officer
$2.82M
@ $346.73 · 2026-02-12
RADHAKRISHNAN RAVIKUMAR S
Chief Technology Officer
$5.35M
@ $356.58 · 2026-02-09
SEEGER LAUREEN E
Officer
$4.60M
@ $360.99 · 2026-02-09
MARRS ANNA
Officer
$9.60M
@ $350.01 · 2026-02-05
PICKETT DENISE
Officer
$8.35M
@ $356.91 · 2026-02-05
JOABAR RAYMOND D
Officer
$538,902
@ $384.93 · 2025-12-12
RUTLEDGE ELIZABETH
Officer
$18.01M
@ $360.21 · 2025-10-31
TABISH DOUGLAS J
Officer
$894,359
@ $355.61 · 2025-10-23
PICKETT DENISE
Officer
$1.75M
@ $350.73 · 2025-10-22
SQUERI STEPHEN J
Chief Executive Officer
$37.03M
@ $329.86 · 2025-09-04
HERENA MONIQUE
Officer
$2.83M
@ $325.88 · 2025-09-03
BUCKMINSTER DOUGLAS E
Officer
$7.67M
@ $326.37 · 2025-09-02
SEEGER LAUREEN E
Officer
$23.37M
@ $296.90 · 2025-08-06
MCNEAL GLENDA G
Officer
$15.47M
@ $309.50 · 2025-07-29
MARRS ANNA
Officer
$1.71M
@ $310.77 · 2025-07-29
MARQUEZ RAFAEL
Officer
$3.56M
@ $296.93 · 2025-05-20
GROSFIELD HOWARD M
Officer
$2.60M
@ $275.50 · 2025-05-06
MCNEAL GLENDA G
Officer
$799,009
@ $264.66 · 2025-04-29
MARRS ANNA
President
$6.32M
@ $287.88 · 2025-03-04
LIEBERMAN QUINN JESSICA
Officer
$897,590
@ $296.43 · 2025-02-26
MCNEAL GLENDA G
Officer
$2.29M
@ $309.96 · 2025-02-11
SQUERI STEPHEN J
Chief Executive Officer
$16.24M
@ $319.45 · 2025-02-06
JOABAR RAYMOND D
Officer
$3.53M
@ $317.01 · 2025-02-05
RADHAKRISHNAN RAVIKUMAR S
Chief Technology Officer
$3.03M
@ $319.17 · 2025-02-05
PICKETT DENISE
Officer
$7.25M
@ $318.69 · 2025-02-05
JOABAR RAYMOND D
Officer
$4.77M
@ $313.94 · 2025-01-28
LE CAILLEC CHRISTOPHE
Chief Financial Officer
$1.82M
@ $303.48 · 2024-11-27
SQUERI STEPHEN J
Chief Executive Officer
$48.90M
@ $286.57 · 2024-11-07
HERENA MONIQUE
Officer
$374,010
@ $287.70 · 2024-11-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
WST
2
Sells (3M)
4
Sells (12M)
Total value (12M): $6.57M
FAVORITE ANNETTE F
Officer
$2.67M
@ $355.03 · 2026-09-15
FAVORITE ANNETTE F
Officer
$2.77M
@ $340.81 · 2026-09-08
WINTERS CHAD
Officer
$269,399
@ $300.67 · 2026-04-27
FAVORITE ANNETTE F
Officer
$859,753
@ $305.20 · 2026-04-27
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
AXP
FearGreed
😐Neutral(51/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
WST
FearGreed
😏Greed(74/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
AXP
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (51)
WST
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (74)
View AXP Full AnalysisView WST Full Analysis

Frequently Asked Questions: AXP vs WST

Is American Express Company or West Pharmaceutical Services, Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, AXP trades at a 31.0% margin of safety (intrinsic value $462 vs. price $319), compared to WST's -160.3% margin of safety (intrinsic $159 vs. $413).

Which stock has a wider economic moat, American Express Company or West Pharmaceutical Services, Inc.?▼

AXP scores 100/100 (Wide moat), while WST scores 68/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is American Express Company in financial distress?▼

AXP's Altman Z-Score of 0.9 places it in the Distress zone, signaling elevated bankruptcy risk. WST scores 13.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, American Express Company or West Pharmaceutical Services, Inc.?▼

WST earns 20.7% ROIC versus AXP's 11.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, American Express Company's or West Pharmaceutical Services, Inc.'s?▼

WST's dividend earns a safety score of 94/100 (Very Safe), compared to AXP's 94/100 (Very Safe). WST has raised its dividend for 3 consecutive years.

AXP vs WST: Which Is the Better Buy in 2026? | SafetyMargin.io